propranolol has been researched along with oxazolidin-2-one in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamal, A; Rao, AB; Rao, MV | 1 |
| Dixon, R; Gillotin, CG; Layton, G; Peck, RW; Posner, J; Seaber, EJ; Weatherley, BC | 1 |
| Deleu, D; Hanssens, Y | 1 |
| Duckmanton, L | 1 |
| Yao, TW; Yu, LS; Zeng, S | 1 |
| Yu, L; Zeng, S | 1 |
| Avital, A; Gross-Isseroff, R; Hermesh, H; Shiloh, R; Stryjer, R; Weizman, A | 1 |
| Alegre, F; Banales, JM; Barbero, R; Carreño, N; Chang, HC; García, M; Herrero, I; Morán, A; Pérez-Vizcaíno, F; Prieto, J; Quiroga, J; Reboredo, M; Rodríguez-Ortigosa, CM; Sangro, B | 1 |
| El-Kadi, AO; Lotfy, HM; Michael, AM; Rezk, MR; Shehata, MA | 1 |
1 review(s) available for propranolol and oxazolidin-2-one
| Article | Year |
|---|---|
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Topics: Acute Disease; Animals; Clinical Trials as Topic; Coronary Circulation; Coronary Vasospasm; Drug Design; Drug Interactions; Humans; Inactivation, Metabolic; Indoles; Meninges; Migraine Disorders; Molecular Structure; Nociceptors; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Pyrrolidines; Randomized Controlled Trials as Topic; Rats; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recurrence; Serotonin Receptor Agonists; Structure-Activity Relationship; Sumatriptan; Treatment Outcome; Triazoles; Tryptamines; Vasoconstrictor Agents | 1999 |
2 trial(s) available for propranolol and oxazolidin-2-one
| Article | Year |
|---|---|
The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90).
Topics: Adrenergic beta-Antagonists; Adult; Area Under Curve; Biotransformation; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Electrocardiography; Female; Half-Life; Humans; Male; Oxazoles; Oxazolidinones; Propranolol; Serotonin Receptor Agonists; Tryptamines | 1997 |
Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Topics: Adrenergic beta-Antagonists; Adult; Akathisia, Drug-Induced; Anticonvulsants; Blood Pressure; Double-Blind Method; Epilepsy; Female; Humans; Inpatients; Male; Middle Aged; Oxazolidinones; Propranolol; Serotonin Receptor Agonists; Severity of Illness Index; Time Factors; Tryptamines | 2009 |
7 other study(ies) available for propranolol and oxazolidin-2-one
| Article | Year |
|---|---|
Stereoselective metabolism of 3-isopropyl-5-(1-naphthoxymethyl)oxazolidine, a prodrug of propranolol.
Topics: Animals; Buffers; Chromatography, High Pressure Liquid; Hydrolysis; Liver; Naphthalenes; Oxazoles; Oxazolidinones; Prodrugs; Propranolol; Rats; Spectrophotometry; Stereoisomerism; Tissue Extracts | 1991 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Drug information incorrect.
Topics: Canada; Contraindications; Drug Interactions; France; Humans; Migraine Disorders; Oxazoles; Oxazolidinones; Propranolol; Serotonin Receptor Agonists; Tryptamines; Vasodilator Agents | 2000 |
In vitro metabolism of zolmitriptan in rat cytochromes induced with beta-naphthoflavone and the interaction between six drugs and zolmitriptan.
Topics: Animals; beta-Naphthoflavone; Cimetidine; Cytochrome P-450 CYP1A2; Diazepam; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluvoxamine; Humans; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Moclobemide; Oxazolidinones; Propranolol; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Species Specificity; Tryptamines | 2003 |
Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Topics: Aspirin; Atenolol; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Cetirizine; Cimetidine; Diffusion; Dose-Response Relationship, Drug; Drug Interactions; Flunarizine; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestinal Mucosa; Oxazolidinones; Permeability; Propranolol; Serotonin Receptor Agonists; Sodium-Hydrogen Exchangers; Tryptamines | 2007 |
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Body Weight; Carbon Tetrachloride; Catecholamines; Common Bile Duct; Cyclic AMP; Drug Synergism; Drug Therapy, Combination; Hypertension, Portal; Infusions, Intravenous; Ligation; Liver Cirrhosis, Experimental; Lypressin; Mesenteric Artery, Superior; Oxazolidinones; Perfusion; Portal Pressure; Propranolol; Rats; Regional Blood Flow; Renal Artery; Splanchnic Circulation; Sympathectomy; Terlipressin; Tryptamines; Vasodilation | 2013 |
A rapid and sensitive HPLC assay of some concomitant anti-migraine drugs.
Topics: Analgesics; Chromatography, High Pressure Liquid; Linear Models; Naproxen; Oxazolidinones; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Tryptamines | 2014 |